Eve Bolland is a Research Assistant at King’s College London, based in the Social, Genetic & Developmental Psychiatry (SGDP) Centre, which she joined in 2023. Her research focuses on the design and delivery of early-phase clinical trials in mental health and neurodevelopmental disorders, with particular emphasis on patient and public involvement and engagement (PPIE), non-invasive neuromodulation, and trial feasibility and acceptability.

Her areas of expertise include clinical trial design and management, research governance and ethics, neuromodulation methods (including rTMS and auditory stimulation), and multimodal assessment using EEG, cognitive tasks, and neuropsychological tests. She has experience coordinating studies within university and NHS settings, working closely with clinicians, statisticians, and PPIE contributors to support rigorous and participant-centred research.

She holds a BSc in Psychology and an MSc in Cognitive Neuroscience from University College London and has previously conducted research at UCL.

Research interests

• Clinical trial design and management in mental health and neurodevelopmental disorders
• Patient and Public Involvement and Engagement (PPIE) and co-produced research
• Non-invasive neuromodulation (e.g. rTMS, auditory stimulation)
• Neurodevelopmental disorders, particularly ADHD
• Neurophysiological biomarkers and multimodal assessment (EEG, cognition, neuroimaging)
• Feasibility, acceptability, and optimisation of early-phase clinical trials
• Inclusive and digital approaches to recruitment and retention

Publications

• Bolland, E., De Burca, A., Wang, S. H., Khalil, A., & McLoughlin, G. (2025). Efficacy of auditory gamma stimulation for cognitive decline: a systematic review of individual and group differences across cognitively impaired and healthy populations. npj Aging.